<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet's disease</z:e> (BD) is associated with renal involvement in about one-third of the cases and a variety of renal lesions have been reported </plain></SENT>
<SENT sid="1" pm="."><plain>A 27-year-old man presented a history of recurrent oral and <z:hpo ids='HP_0003249'>genital ulcers</z:hpo>, associated with pseudofoliculitis and <z:hpo ids='HP_0001369'>arthritis</z:hpo> in his left knee </plain></SENT>
<SENT sid="2" pm="."><plain>The first laboratory tests revealed: <z:chebi fb="20" ids="16199">urea</z:chebi> = 53mg/dL, <z:chebi fb="0" ids="16737">creatinine</z:chebi> = 1.8 mg/dL </plain></SENT>
<SENT sid="3" pm="."><plain>The urinalysis showed <z:mp ids='MP_0011418'>leukocyturia</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>Initial treatment with <z:chebi fb="0" ids="29007">ceftriaxone</z:chebi>, thalidomide and <z:chebi fb="0" ids="8382">prednisone</z:chebi> was instituted </plain></SENT>
<SENT sid="5" pm="."><plain>He became clinically stable, with <z:mpath ids='MPATH_458'>normal</z:mpath> renal function, but presenting <z:hpo ids='HP_0000790'>hematuria</z:hpo> and <z:hpo ids='HP_0000093'>proteinuria</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>One year later the patient presented dark urine </plain></SENT>
<SENT sid="7" pm="."><plain>The new laboratory tests showed <z:chebi fb="20" ids="16199">urea</z:chebi>=58 mg/dL, <z:chebi fb="0" ids="16737">creatinine</z:chebi> = 1.4 mg/dL, and mild <z:hpo ids='HP_0000093'>proteinuria</z:hpo> (500-1000 mg/24h) </plain></SENT>
<SENT sid="8" pm="."><plain>Two years later the <z:hpo ids='HP_0000093'>proteinuria</z:hpo> was 2230 mg/day </plain></SENT>
<SENT sid="9" pm="."><plain>The renal biopsy showed one glomerulus with severe <z:mp ids='MP_0005264'>glomerular sclerosis</z:mp>, mild <z:hpo ids='HP_0000092'>tubular atrophy</z:hpo>, mild interstitial <z:mp ids='MP_0003045'>fibrosis</z:mp> and thickening of arterial walls </plain></SENT>
<SENT sid="10" pm="."><plain>Treatment with <z:chebi fb="0" ids="3380">captopril</z:chebi> was started to decrease <z:hpo ids='HP_0000093'>proteinuria</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>Two years later, the patient presented <z:chebi fb="0" ids="16737">creatinine</z:chebi> = 1.7 mg/dL and <z:hpo ids='HP_0000093'>proteinuria</z:hpo> = 2509 mg/day </plain></SENT>
<SENT sid="12" pm="."><plain>A new renal biopsy evidenced proliferative crescentic <z:hpo ids='HP_0000099'>glomerulonephritis</z:hpo>, with diffuse granullary deposits of IgA, IgM and C3 </plain></SENT>
<SENT sid="13" pm="."><plain>It was instituted pulsotherapy with metilprednisolone, monthly endovenous <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> and maintenance <z:chebi fb="0" ids="8382">prednisone</z:chebi> </plain></SENT>
<SENT sid="14" pm="."><plain>The patient became clinically stable, with <z:chebi fb="0" ids="16737">creatinine</z:chebi> of 1.3 mg/dL and <z:hpo ids='HP_0000093'>proteinuria</z:hpo> of 500 mg/day </plain></SENT>
<SENT sid="15" pm="."><plain>BD could be one of the various causes of secondary IgA <z:hpo ids='HP_0000123'>nephritis</z:hpo> </plain></SENT>
<SENT sid="16" pm="."><plain>It is important to periodically perform renal function evaluation in patients with BD, through urinalysis and measurement of serum <z:chebi fb="0" ids="16737">creatinine</z:chebi> and its clearance, in order to detect any abnormality and provide an early adequate treatment </plain></SENT>
</text></document>